142 related articles for article (PubMed ID: 23319301)
1. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.
Fischer B; Jones W; Rehm J
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):438-42. PubMed ID: 23319301
[TBL] [Abstract][Full Text] [Related]
2. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.
Fischer B; Jones W; Urbanoski K; Skinner R; Rehm J
Drug Alcohol Rev; 2014 Jan; 33(1):19-26. PubMed ID: 24261474
[TBL] [Abstract][Full Text] [Related]
3. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016.
Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P
Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407
[TBL] [Abstract][Full Text] [Related]
4. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.
Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG
Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123
[TBL] [Abstract][Full Text] [Related]
5. Recent changes in trends of opioid overdose deaths in North America.
Imtiaz S; Shield KD; Fischer B; Elton-Marshall T; Sornpaisarn B; Probst C; Rehm J
Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):66. PubMed ID: 32867799
[TBL] [Abstract][Full Text] [Related]
6. Trends and sex differences in prescription opioid deaths in British Columbia, Canada.
Gladstone EJ; Smolina K; Morgan SG
Inj Prev; 2016 Aug; 22(4):288-90. PubMed ID: 26195562
[TBL] [Abstract][Full Text] [Related]
7. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010.
Fischer B; Jones W; Krahn M; Rehm J
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1269-77. PubMed ID: 21755568
[TBL] [Abstract][Full Text] [Related]
8. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.
Shield KD; Jones W; Rehm J; Fischer B
Pain Res Manag; 2013; 18(2):69-74. PubMed ID: 23662288
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.
Fischer B; Jones W; Rehm J
BMC Health Serv Res; 2014 Feb; 14():90. PubMed ID: 24572005
[TBL] [Abstract][Full Text] [Related]
11. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
Nguyen HV; Mital S; Bugden S; McGinty EE
JAMA Intern Med; 2024 Mar; 184(3):256-264. PubMed ID: 38227344
[TBL] [Abstract][Full Text] [Related]
12. Harms of prescription opioid use in the United States.
Imtiaz S; Shield KD; Fischer B; Rehm J
Subst Abuse Treat Prev Policy; 2014 Oct; 9():43. PubMed ID: 25352167
[TBL] [Abstract][Full Text] [Related]
13. Drug-related overdose deaths in British Columbia and Ontario, 1992-2004.
Fischer B; Popova S; Rehm J; Ivsins A
Can J Public Health; 2006; 97(5):384-7. PubMed ID: 17120877
[TBL] [Abstract][Full Text] [Related]
14. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.
Gladstone E; Smolina K; Morgan SG; Fernandes KA; Martins D; Gomes T
CMAJ; 2016 Mar; 188(4):E67-E72. PubMed ID: 26622006
[TBL] [Abstract][Full Text] [Related]
16. Opioid analgesics and rates of fatal drug poisoning in the United States.
Paulozzi LJ; Ryan GW
Am J Prev Med; 2006 Dec; 31(6):506-11. PubMed ID: 17169712
[TBL] [Abstract][Full Text] [Related]
17. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.
Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E
Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558
[TBL] [Abstract][Full Text] [Related]
18. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.
Dhalla IA; Mamdani MM; Sivilotti ML; Kopp A; Qureshi O; Juurlink DN
CMAJ; 2009 Dec; 181(12):891-6. PubMed ID: 19969578
[TBL] [Abstract][Full Text] [Related]
19. Determinants of trends in prescription opioid use in British Columbia, Canada, 2005-2013.
Smolina K; Gladstone E; Morgan SG
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):553-9. PubMed ID: 26947145
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
